News
| 09-18 17:43 | Avantis | Other | Biotech. $LLY — orals expanding the market, or trading injectable economics for cash-pay economics? $MRNA — Intismeran turns a per-patient therapy into a real franchise, or the readout bought optionality the balance sheet still has to finance? @verantaxyz on X ↗ |
AvantisTags are automatic and can be wrong.